In this article (1), which was published in the September 2009 issue of Cancer Epidemiology, Biomarkers & Prevention, the FOLH1 SNP rs202676 was referred to incorrectly as FOLH1 “1561T>C.” The correct designation is as follows:
rs202676 occurs in exon 2 of FOLH1/GCPII (referred to as 223T>C or 484T>C), corresponding to amino acid substitution Y75H. The 1561C>T polymorphism (also referred to as 1684C>T) occurs in exon 13 of FOLH1, is identified as rs61886492, and corresponds to amino acid substitution H475Y.
References
1
Collin
SM
, Metcalfe
C
, Zuccolo
L
, Lewis
SJ
, Chen
L
, Cox
A
, Davis
M
, Lane
JA
, Donovan
J
, Smith
GD
, Neal
DE
, Hamdy
FC
, Gudmundsson
J
, Sulem
P
, Rafnar
T
, Benediktsdottir
KR
, Eeles
RA
, Guy
M
, Kote-Jarai
Z
, UK Genetic Prostate Cancer Study Group
, Morrison
J
, Al Olama
AA
, Stefansson
K
, Easton
DF
, Martin
RM
. Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis
. Cancer Epidemiol Biomarkers Prev
2009
;18
:2528
–39
.©2010 American Association for Cancer Research.
2010